Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 628

Results For "AI"

8284 News Found

Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States


New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming
Sustainability | April 11, 2022

Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming

Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products


Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
Biotech | April 11, 2022

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology


Crosscope collaborates with Waleed Pharmacy to enter Oman
Digitisation | April 11, 2022

Crosscope collaborates with Waleed Pharmacy to enter Oman

Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features


Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
Biotech | April 11, 2022

Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab

Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones


CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
Biotech | April 11, 2022

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid

These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection


Intuitive launches My Intuitive App
Digitisation | April 11, 2022

Intuitive launches My Intuitive App

The app serves as a single, integrated, personalized customer platform for da Vinci surgeons


Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas


Lonza signs manufacturing deal with Asher Biotherapeutics
Biotech | April 11, 2022

Lonza signs manufacturing deal with Asher Biotherapeutics

Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein